-
Taxonomy & unit
-
us-gaap: CNY and USD
-
Description
-
Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.
-
Summary
-
Gracell Biotechnologies Inc. quarterly Liabilities history and growth rate from Q4 2019 to Q2 2023.
- Gracell Biotechnologies Inc. Liabilities for the quarter ending June 30, 2023 was ¥241M, a 15.5% decline year-over-year.
Liabilities, Quarterly (CNY)
Liabilities, YoY Quarterly Growth (%)